Cerenome, Inc.
CNSY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001095981
No open-market purchases or sales by Cerenome, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.89M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Cerenome, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q2 2022
- Shares held
- 3.55M
- −31.4K (−0.9%) vs. Q2 2022
- Total value
- $1.58M
- −$353.2K (−18.3%) vs. Q2 2022
- New holders
- 3
- 4 more added
- Sold out
- 1
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.89M |
| Q1 2026 | 25 | $1.49M |
| Q4 2025 | 27 | $5.92M |
| Q3 2025 | 23 | $3.57M |
| Q2 2025 | 19 | $131.6K |
| Q1 2025 | 17 | $368.7K |
| Q4 2024 | 11 | $779.9K |
| Q3 2024 | 11 | $980.5K |
| Q2 2024 | 12 | $1.00M |
| Q1 2024 | 10 | $181.8K |
| Q4 2023 | 12 | $247.4K |
| Q3 2023 | 12 | $117.9K |
| Q2 2023 | 7 | $205.5K |
| Q1 2023 | 25 | $588.3K |
| Q4 2022 | 30 | $872.1K |
| Q3 2022 | 28 | $1.58M |
| Q2 2022 | 26 | $1.93M |
| Q1 2022 | 23 | $3.26M |
| Q4 2021 | 24 | $2.03M |
| Q3 2021 | 18 | $2.48M |
| Q2 2021 | 22 | $4.11M |
| Q1 2021 | 18 | $717.0K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cerenome, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 6 | $0 | 0.00% | −118,421−100.0% | Reduced |
| Financial Perspectives, Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 151 | $0 | 0.00% | +1+0.7% | Added |
| Barclays PLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 54 | $0 | 0.00% | +8+17.4% | Added |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,003 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,696 | $4.00K | 0.00% | −10,449−51.9% | Reduced |
| Warberg Asset Management LLC | 10,000 | $5.00K | 0.00% | −15,100−60.2% | Reduced |
| Ashton Thomas Private Wealth, LLC | 12,230 | $5.44K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 12,403 | $6.00K | 0.00% | −8,986−42.0% | Reduced |
| UBS Group AG | 16,208 | $7.00K | 0.00% | +2,520+18.4% | Added |
| Citadel Advisors LLC | 16,772 | $7.00K | 0.00% | +16,772 | New |
| Northern Trust Corp | 32,089 | $14.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 34,414 | $15.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 33,539 | $15.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 33,600 | $15.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 42,300 | $19.0K | 0.00% | −7,100−14.4% | Reduced |
| Susquehanna International Group, LLP | 46,232 | $21.0K | 0.00% | +46,232 | New |
| Two Sigma Securities, LLC | 64,107 | $29.0K | 0.00% | +64,107 | New |
| Renaissance Technologies LLC | 70,900 | $32.0K | 0.00% | −30,193−29.9% | Reduced |
| BlackRock Inc. | 104,427 | $46.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 258,437 | $115.0K | 0.00% | 00.0% | Unchanged |
| Otter Creek Advisors, LLC | 330,168 | $147.0K | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,092,568 | $486.0K | 0.00% | +237,304+27.7% | Added |
| Parkman Healthcare Partners LLC | 1,325,025 | $590.0K | 0.17% | −208,050−13.6% | Reduced |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −16−100.0% | Sold out |